{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:33:51Z","timestamp":1781753631911,"version":"3.54.5"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Ophthalmol"],"published-print":{"date-parts":[[2008,8,11]]},"DOI":"10.1001\/archophthalmol.2008.1","type":"journal-article","created":{"date-parts":[[2008,8,11]],"date-time":"2008-08-11T16:18:35Z","timestamp":1218471515000},"page":"1161","source":"Crossref","is-referenced-by-count":77,"title":["Intravitreous Bevacizumab as Anti\u2013Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study"],"prefix":"10.1001","volume":"126","author":[{"given":"Lingkun","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["Archives of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/420730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:17:55Z","timestamp":1481933875000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/archophthalmol.2008.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,11]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8,11]]}},"URL":"https:\/\/doi.org\/10.1001\/archophthalmol.2008.1","relation":{},"ISSN":["0003-9950"],"issn-type":[{"value":"0003-9950","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,11]]}}}